Cassava Sciences, Inc.

    Jurisdiction
    United States
    LEI
    529900XA0UG5JXABYF08
    ISIN
    US14817C1071 (SAVA)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 51 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€112.08M
    EBIT margin
    0.0%
    Net income
    -€106.11M
    Net margin
    0.0%

    Statement period: - (published )

    Dividends

    Last dividend amount
    $0.75
    Ex date
    Payment date

    Earnings Calls

    Latest earnings call: November 7, 2024

    Add to watchlist

    Notifications